IP Library Granted Patent US 9,897,532
Granted Patent B2
US 9,897,532 · App. 14/552,256 · Granted Feb 20, 2018

Method and device for high throughput cell deformability measurements

Inventors: Dino Di Carlo (Los Angeles, CA); Daniel R. Gossett (Los Angeles, CA); Henry T. K. Tse (San Francisco, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
G01N15/1463B01L3/50273B01L3/502715B01L3/502776C12Q1/02G01N15/1404G01N15/1459G01N15/1484G01N33/487G01N33/574G06F19/10B01L2200/0605B01L2200/0647B01L2200/0652B01L2300/0654B01L2300/0864G01N2015/0065G01N2015/1006G01N2015/149G01N2015/1415G01N2015/1495G01N2015/1497G01N2800/7028
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,897,532
App. No.
14/552,256
Granted
Feb 20, 2018
Kind
B2
Abstract

A system is disclosed that enables the automated measurement of cellular mechanical parameters at high throughputs. The microfluidic device uses intersecting flows to create an extensional flow region where the cells undergo controlled stretching. Cells are focused into streamlines prior to entering the extensional flow region. In the extensional region, each cell's deformation is measured with an imaging device. Automated image analysis extracts a range of independent biomechanical parameters from the images. These may include cell size, deformability, and circularity. The single cell data that is obtained may then be used to in a variety of ways. Scatter density plots of deformability and circularity may be developed and displayed for the user. Mechanical parameters such as deformability and circularity may be gated or thresholded to identify certain cells of interest or sub-populations of interest. Similarly, the mechanical data obtained using the device may be used as cell signatures.

Claims (38)

1. A system for measuring a change in a morphological parameter of a cell comprising:

a substrate containing first and second microfluidic channels;

an extensional region comprising an intersection of the first and second microfluidic channels, wherein the first and second microfluidic channels intersect in substantially opposite directions;

a focusing region located in at least one of the first and second microfluidic channels upstream of the extensional region, wherein the focusing region focuses cells passing there through into a stream of cells located along one or more lateral streamlines;

at least one outlet channel coupled to the extensional region;

an optical collector configured to capture multiple records of diffracted or refracted light from each cell passing through the extensional region;

a pump configured to flow a plurality of cells into at least one of the first and second microfluidic channels and through the extensional region, wherein the plurality of cells flow through the extensional region and are not trapped therein with each cell passing through the extensional region in less than 500 μs; and

at least one processor operably coupled to the optical collector and configured to calculate a change in a morphological parameter of each cell passing through the extensional region based on the multiple records, wherein the change in the morphological parameter comprises a dimensional change of each cell passing through the extensional region.

2. The system of claim 1 , wherein the morphological parameter is selected from the group of cell size, cell deformability, cell circularity, cell shape, and cell granularity of cells passing through the extensional region.

3. The system of claim 1 , wherein the first and second microfluidic channels are coupled to a common inlet at an upstream location with respect to the extensional region and the pump is coupled to the common inlet.

4. The system of claim 1 , wherein the at least one outlet channel comprises first and second outlet channels arranged substantially perpendicular to the first and second microfluidic channels.

5. The system of claim 3 , wherein only one of the first and second microfluidic channels carry cells therein.

6. The system of claim 1 , wherein the optical collector comprises a photodiode or photomultiplier tube.

7. The system of claim 1 , wherein the optical collector comprises a camera.

8. The system of claim 1 , wherein the at least one processor is operably connected to the pump to control a flow rate from the pump.

9. The system of claim 1 , wherein the at least one processor is part of a computer.

10. The system of claim 1 , wherein the optical collector collects more than 50,000 records per second.

11. A method of diagnosing metastatic cancer comprising:

focusing a sample containing a plurality of cells into at least one of first and second microfluidic channels dimensioned to carry cells therein;

intersecting the flows from the first and second microfluidic channels into an extensional region configured to apply stress to the plurality of cells passing through the extensional region, wherein each cell passes through the extensional region in less than 500 μs;

obtaining a plurality of image frames of the plurality of cells, wherein the plurality of image frames contain images of the plurality of cells prior to entering the extensional region and during exposure to stress within the extensional region;

measuring one or more dimensional parameters of each of the plurality of cells from the plurality of image frames prior to entering the extensional region and during exposure to the stress in the extensional region using at least one processor;

gating each of the plurality of cells based on the one or more measured dimensional parameters using the at least one processor; and

using the at least one processor to diagnose the sample as positive for metastatic cancer with a gating function based on a distribution of the dimensional parameters for the plurality of cells.

12. The method of claim 11 , wherein the one or more measured dimensional parameters comprises initial diameter and deformability.

13. The method of claim 12 , wherein the gating function comprises identifying cells having an initial diameter and a deformability above pre-set threshold values.

14. The method of claim 13 , wherein diagnosing the sample as positive for metastatic cancer occurs when a percentage of the plurality of cells having an initial diameter and a deformability above the pre-set threshold values exceeds a pre-set threshold percentage.

15. The method of claim 11 , wherein the sample comprises pleural fluid from a subject.

16. A method of discriminating between pluripotent stem cells and differentiated cells comprising:

focusing a sample containing a plurality of cells into at least one of first and second microfluidic channels dimensioned to carry cells therein;

intersecting the flows from the first and second microfluidic channels into an extensional region configured to apply stress to the plurality of cells passing into the extensional region, wherein each cell passes through the extensional region in less than 500 μs;

obtaining a plurality of image frames of the plurality of cells, wherein the plurality of image frames contain images of the plurality of cells prior to entering the extensional region and during exposure to stress within the extensional region;

measuring one or more dimensional parameters of each the plurality of cells from the plurality of image frames prior to entering the extensional region and during exposure to the stress in the extensional region using at least one processor;

gating the plurality of cells based on the one or more measured dimensional parameters according to a gating function using the at least one processor; and

the at least one processor identifying pluripotent stem cells and differentiated cells based on the gating operation.

17. The method of claim 16 , wherein the gating function comprises a threshold.

18. The method of claim 17 , wherein the one or more dimensional parameters comprise deformability or circularity.

19. The method of claim 18 , wherein pluripotent stem cells have deformability or circularity on one side of a threshold and wherein the differentiated cells have deformability or circularity on another side of the threshold.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2022
From: DI CARLO, DINO; GOSSETT, DANIEL R.; TSE, HENRY T.K.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 059932/0644 →
Continuity (3)
Continuation 13823109
Provisional Application 61385268 · Sep 22, 2010
Related Publication 20160231224A1 · Aug 11, 2016